| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $9.6M | +26.0% |
| Cost of Revenue | $4.2M | +36.3% |
| Gross Profit | $5.4M | +19.1% |
| R&D Expense | $3.2M | +17.7% |
| SG&A Expense | $17.6M | -5.1% |
| Operating Income | -$15.4M | +7.9% |
| Interest Expense | $1.8M | +384.6% |
| Pre-tax Income | -$18.7M | +35.9% |
| Net Income | -$18.7M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $570K | -95.3% |
| Accounts Receivable | $1.2M | -39.0% |
| Inventory | $2.3M | +177.2% |
| Current Assets | $4.7M | -69.2% |
| Total Assets | $6.5M | -61.0% |
| Current Liabilities | $11.2M | +129.3% |
| Total Liabilities | $26.4M | +40.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | +10.7% |
| Capital Expenditures | $30K | +0.0% |
| Investing Cash Flow | -$30K | +0.0% |
| Financing Cash Flow | $2.0M | -92.0% |
| Free Cash Flow | -$13.6M | +10.6% |
| +35.9% |
| EPS (Basic) | -$0.38 | +43.5% |
| Stockholders' Equity |
| -$19.8M |
| -825.3% |